**Core Concept**
Teduglutide is used in the treatment of short bowel syndrome, a condition characterized by a significant loss of intestinal tissue. The underlying principle involves enhancing intestinal absorption. **Glucagon-like peptide-2 (GLP-2)** analogs play a crucial role in this process.

**Why the Correct Answer is Right**
Teduglutide works by promoting intestinal mucosal growth, improving absorption, and reducing gastric emptying and secretion. It is a **GLP-2** analog, which mimics the action of the natural hormone, enhancing intestinal adaptation and reducing the need for parenteral nutrition in patients with short bowel syndrome.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect as it does not relate to the mechanism of action of Teduglutide.
**Option B:** Incorrect because it is not the primary action of Teduglutide in short bowel syndrome.
**Option C:** Incorrect as it is not relevant to Teduglutide's effect on the intestine.

**Clinical Pearl / High-Yield Fact**
Teduglutide increases intestinal absorption by promoting mucosal growth, which is crucial for managing short bowel syndrome. Remember, **GLP-2** analogs like Teduglutide are key in enhancing intestinal adaptation.

**Correct Answer:** D. Teduglutide is a glucagon-like peptide-2 analog.